Definitive Contract 75A50126C00002
- Not listed
- This is a $127,809 firm fixed-price purchase order awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Vericel Corporation, a for-profit medical technology company based in Cambridge, Massachusetts. The contract is for the supply of EPICEL-CEA skin grafts, which are advanced cell therapy products used in orthopedic and reconstructive medical procedures. Vericel specializes in developing innovative cell and tissue-based therapies, and this contract supports the...
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Vericel Corporation, a for-profit manufacturer of advanced cell therapy products for sports medicine and severe burn care. The $56,171 contract is for the delivery of surgical implants, membranes, and other biological products to support healthcare services for veterans at VA facilities. The contract has a completion date of May 29, 2024 and was awarded on March...
- This is a $97,050.00 firm fixed-price purchase order contract awarded by the U.S. Army Medical Command to Vericel Corporation, a for-profit medical technology company based in Cambridge, Massachusetts. The contract is for the provision of Cultured Epicel-CEA, which are advanced cell therapy products used in orthopedic and reconstructive medical procedures. The contract has no set-aside designation, indicating it was competed on the open market. Vericel Corporation is a regular recipient of...
- The Department of the Army Medical Command awarded a Firm Fixed Price Purchase Order contract to Vericel Corporation, a for-profit manufacturer of medical goods, to provide Cultured EPICEL-CEA skin grafts. The contract has a potential value of $228,275.00 and a completion date of January 3, 2019. The contract was awarded on December 31, 2018 without a set-aside designation. Vericel Corporation is a leader in advanced cell therapies for the sports medicine and severe burn care markets, and has...
- This federal contract award, valued at $56,171.00, was issued by the Veterans Integrated Service Network 12 (VISN 12), which is part of the U.S. Department of Veterans Affairs (VA). The contract was awarded to Vericel Corporation, a for-profit manufacturer of advanced cell therapy products, primarily for the supply of the company's MACI cultured chondrocyte implant and other surgical implants, membranes, and biological products. The contract is a firm fixed price purchase order with a completion...
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Vericel Corporation, a for-profit manufacturer of advanced cell therapy products. The $52,252 contract is for the delivery of surgical implants, with a period of performance ending on November 22, 2023. Vericel Corporation is a registered federal contractor that has secured over 50 contracts with the VA and the Defense Health Agency since 2015, primarily to provide specialized medical...
- This federal contract award is for the supply of a surgical implant (tissue) by Vericel Corporation, a for-profit manufacturer of advanced cell therapy products, to the Department of Veterans Affairs (VA). The $52,252.00 firm fixed price purchase order is not set aside and has a completion date of June 26, 2023. Vericel, which has been a registered federal contractor since 2015, has secured over 50 contracts with the VA's Veterans Health Administration, primarily to provide specialized medical...
- Vericel Corporation was awarded a $69.8K firm fixed-price purchase order by Veterans Integrated Service Network 19 (VISN 19) for prosthetic implants, with a completion deadline of May 13, 2026. The contract, which was not subject to any set-aside designation, reflects open market competition and represents a continuation of Vericel's established relationship with the Department of Veterans Affairs. The place of performance is Vericel's headquarters in Cambridge, Massachusetts. This award...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $52,252 firm fixed price purchase order to Vericel Corporation of Cambridge, Massachusetts. The contract is for the delivery of membrane products to support VA's healthcare programs. The prime contractor, Vericel, will provide the membrane materials to VA medical facilities in the New England region under the terms of this purchase order, which runs from October 10, 2023 through...
- This federal contract award is for the supply of IMPLANT products to the U.S. Department of Veterans Affairs (VA), specifically to the Veterans Integrated Service Network 12 (VISN 12) within the VA's Veterans Health Administration. The prime contractor is Vericel Corporation, a for-profit manufacturer of advanced cell therapy products, primarily for sports medicine and severe burn care applications. The contract is a firm fixed price purchase order with a total ceiling value of $56,171. It has...
Vericel Corporation, a Cambridge, Massachusetts-based medical technology company specializing in advanced cell therapy and tissue engineering, was awarded a definitive contract valued at approximately $192 million by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR/BARDA) for non-surgical debridement products. The contract, which carries a cost-plus-fixed-fee pricing structure with no set-aside designation, was awarded on April 1, 2026, and extends through March 31, 2036. This procurement supports BARDA's national emergency preparedness efforts by establishing a vendor-managed inventory of enzymatic debridement products designed to treat severe burn injuries and blast trauma wounds during mass casualty incidents. Under this extended contract, Vericel will maintain a preparedness inventory of advanced debridement solutions that can be rapidly deployed during national emergencies, with monthly reporting requirements to BARDA. The products are intended to provide more selective removal of necrotic burned tissue earlier in patient care, thereby reducing resource burden and improving outcomes. This award builds upon BARDA's existing vendor-managed inventory arrangement using Project BioShield funding and represents a significant expansion of Vericel's federal healthcare portfolio, which has historically focused on orthopedic and reconstructive products supplied primarily to the Department of Veterans Affairs.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Presolicitation Notice - NonSurgical Debridement | 75A50125R00007 | Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response | Pre-Solicitation 1/3 | 6/27/25, 9:11 AM | |
NonSurgical Debridement | 75A50125R00007 | Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response | Solicitation 2/3 | 7/13/25, 10:23 PM | |
NonSurgical Debridement | 75A50126C00002 | Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response | Award Notice 3/3 | 4/2/26, 10:36 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.9m | 3/31/26 |